Skip to main content
. 2015 Apr 29;(4):CD008138. doi: 10.1002/14651858.CD008138.pub2
Study Reason for exclusion
Alizadeh 2014 Used oral medication
Amos 1994 Used a composite symptom score only
Attila 1993 Used a mixture of drugs
Boyle 1986 Used a composite outcome score only
Brown 1990 Used a composite outcome score only
Cauwenbergh 1986 Used a composite outcome score only
Chappell 2014 Used a composite outcome score only
Cheng 2001 Not a randomised trial (as assessed by native speaker)
Cicek 2009 Does not involve antifungal drugs
Comert 2007 Used a composite outcome score only
CTRI/2009/091/001079 Used a combination of antifungals for treatment
Davies 1999 Combined antifungal with another drug having a different mode of action
Efalith Trial Group 1992 Used a mixture of lithium and zinc
Emad 2000 Abstract with insufficient data; no full text retrieved
Emtestam 2012 Drugs used in this trial were not antifungal
Ermosilla 2005 Outcome variable used is a composite of symptom scores; this falls within our exclusion criteria
Ernst 1990 Non-randomised study
Ford 1984 Evaluated orally administered ketoconazole
Gayko 2006 Ketoconazole was compared with a combination of ketoconazole and another drug
Goldust 2013(a) No outcomes reported
Gupta 2006 This was a qualitative review
Humke 2002 Conference abstract; not able to retrieve full text
Iraji 2005 Abstract; did not provide enough data; not able to retrieve full text
Iudica 2001 This was a commentary on another article (Parsad 2001a)
Jensen 2009 Abstract with insufficient data; not able to retrieve full text
Kaszuba 2005 Study evaluated orally administered Itraconazole
Koca 2003 Used a composite outcome score only
Kozlowska 2007 Used a composite outcome score only
Li 1996 Not a randomised trial as assessed by native speaker
Loden 2000 Combined antifungal with a drug having a different mode of action
Lorette 2006 Combined 2 antifungals versus a third antifungal (or placebo) (ciclopiroxolamine/zinc pyrithione)
Meyer-Rohn 1979 This study deals with patients with non-seborrhoeic dermatitis
NCT00703846 Open-label phase 4 trial without control group
NCT01139749 Used oral medication
Ozcan 2007 Metronidazole is not an antifungal
Parsad 2001 Metronidazole is not an antifungal
Pedrinazzi 2009 Used peat; we excluded herbal treatments
Peter 1995 Used a composite outcome score only
Pierard-Franchimont 2002b Used a composite outcome score only
Pierard-Franchimont 2002c Outcome variables in this study were sebum excretion rate and percentage of anagen hair, which did not fulfil our inclusion criteria
Prensner 2003 This is a commentary on a study that was previously conducted
Quadri 2005 Authors (Milani) were contacted; data not available anymore
Rigoni 1989 Non-randomised study
Salmanpoor 2012 This was a Letter to the Editor
Scaparro 2001 Used oral medication
Schmidt-Rose 2011 Used a composite outcome score only
Schwartz 2013 Combined antifungal with a drug having a different mode of action (zinc pyrithione and climbazole)
Seite 2009 Combined antifungal with a drug having a different mode of action
Siadat 2006 Metronidazole is not an antifungal
Sparavigna 2013 Combined 2 antifungals vs placebo
Squire 2002 Combined antifungal with a drug having a different mode of action
Syed 2008 Herbal extract
Trznadel-Grodzka 2012 This study was not a clinical trial
Vena 2005 Used a composite outcome score only
Xu 1996 Not a randomised trial (as assessed by native speaker)